All In MedTech

Device Trial Radar · NCT07714694

Consumer Evaluation of an Investigational Intermittent Catheter

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

68

Actual

Start

Jul 9, 2026

Primary completion

Nov 6, 2026

Study completion Nov 6, 2026

Sponsor

Lead sponsor
Hollister IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Jul 20, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical study is designed to evaluate the initial safety and performance of an investigational intermittent urinary catheter in people who use intermittent catheterization. Participants will use the study catheter and provide feedback on their experience, including ease of insertion, advancement through the urethra, bladder drainage, withdrawal, comfort, confidence, satisfaction, and overall ease of use. Safety will be evaluated through reported health changes and adverse events. Device performance and user experience will be assessed using participant questionnaires and comparisons with the participant's current intermittent catheter, including questions related to catheter handling, comfort during catheterization, perceived ability to empty the bladder, likelihood of future use, and product preference. The study is intended to generate descriptive information on the initial clinical use of the investigational catheter and to help characterize its safety, usability, comfort, satisfaction, and performance relative to participants' current intermittent catheter products.

Conditions

  • Urinary Retention
  • Neurogenic Bladder

Interventions

  • An intermittent urethral urinary catheter with a tip, tube and drainage eyeletsDevice

    An intermittent urethral urinary catheter with a tip, tube and drainage eyelets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Health Changes and Adverse Events During Usual-Catheter and Investigational-Catheter UseTime frame: Through completion of both catheter-use periods, approximately 6 to 20 days

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hollister Incorporated

    Libertyville, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.